DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2263665/entera-bio-ltd-entx-stock-slides-as-market-rises-facts-to-know-before-you-trade?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2263665 Apr 26, 2024 - The latest trading day saw Entera Bio Ltd. (ENTX) settling at $1.98, representing a -1% change from its previous close. 0

https://seekingalpha.com/news/4094442-takeda-leaves-industry-trade-group-bio?source=feed_sector_healthcare Apr 25, 2024 - Takeda Pharmaceutical (TAK) joins Pfizer (PFE) in leaving the Biotechnology Innovation Organization, the top biotech lobbying group. Read more here. 0

https://www.zacks.com/stock/news/2258103/why-the-market-dipped-but-entera-bio-ltd-entx-gained-today?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2258103 Apr 18, 2024 - In the closing of the recent trading day, Entera Bio Ltd. (ENTX) stood at $2.24, denoting a +0.9% change from the preceding trading day. 0

https://seekingalpha.com/news/4091115-telesis-bio-stock-slips-amid-new-ceo?source=feed_sector_healthcare Apr 18, 2024 - Telesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here. 0

https://seekingalpha.com/news/4091083-zura-bio-stock-jumps-on-plans-to-raise-1125m-in-private-financing?source=feed_sector_healthcare Apr 18, 2024 - Zura Bio (ZURA) shares jumped around 12% after the immunology company entered into subscription agreements for a private placement. 0

https://www.zacks.com/stock/news/2257849/bio-rad-laboratories-bio-to-post-q1-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257849 Apr 18, 2024 - The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth. 0

https://www.zacks.com/stock/news/2257012/2seventy-bio-tsvt-rises-more-than-50-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2257012 Apr 17, 2024 - The FDA's recent nod to 2seventy bio's (TSVT) Abecma in earlier lines of treatment for relapsed/refractory multiple myeloma is a positive. Also, the R&D asset divestiture to Regeneron is saving costs. 0

https://seekingalpha.com/news/4089763-mustang-bio-stock-tumbles-amid-news-of-mass-layoffs?source=feed_sector_healthcare Apr 15, 2024 - Mustang Bio (MBIO) stock tumbled 27% Monday in the wake of news that the company plans to cut around 81% of its workforce to conserve cash. Read more here. 0

https://www.fool.com/investing/2024/04/15/is-bluebird-bio-stock-a-buy/?source=iedfolrf0000001 Apr 15, 2024 - This small biotech is struggling to fly -- and investors should probably steer clear. 0

https://www.fool.com/investing/2024/04/13/better-buy-bluebird-bio-vs-novavax/?source=iedfolrf0000001 Apr 13, 2024 - Who wins this face-to-face between two beaten-down biotechs? 0